Primary record
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]glutamic Acid; (+/-)-Methotrexate; DL-Amethopterin; DL-Methotrexate; NSC 117356;
- 库存
- 4,892 克
- 纯度
- 99.4 %
- CAS
- 60388-53-6
化合物标识与属性
- CAS
- 60388-53-6
- PubChem CID
- 4112
- SMILES
- CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
- Canonical SMILES
- CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1
名称与同义词
- methotrexate
- Amethopterin
- DL-Amethopterin
- DL-Methotrexate
- Methylaminopterin
- Abitrexate
- Trexall
- Mexate
- Ledertrexate
- Rheumatrex
- Antifolan
- (+)-Amethopterin
- (+/-)Amethopterin
- D-Amethopterin
- Amethopterine
- Methotextrate
- Metatrexan
- Methotrexat
- Emtexate
- Folex
- Hdmtx
- Racemethotrexate
- rac-methoetrexat
- L-Amethopterin
- Mexate-Aq
- Methotrexat-Ebewe
- Methylaminopterinum
- 60388-53-6
- (+-)-Methotrexate
- Amethopterin (R,S)
- ( )Amethopterin
- Methotrexate hydrate
- Prestwick_753
- Folex (Salt/Mix)
- METHOTREXATE(+/-)
- 4-Amino-10-methylfolic acid
- 6-Mtx (DL)
- (+/-)-Amethopterin
- Methotrexate (hydrate)
- Methotrexate-methyl-d3
- DL-MTX
- Methotrexate, (+/-)-
- D(-)-AMETHOPTERIN
- CHEMBL426
- AC1L1HFS
- Methotrexate;DL-Amethopterin
- Prestwick0_000373
- Prestwick1_000373
- Prestwick2_000373
- Prestwick3_000135
- Prestwick3_000373
- 99ITO15X8S
- Methotrexate Impurity 64
- Methotrexate, (A+-)-
- TCMDC-123832
- RefChem:1089151
- CHEMBL156
- L(+)-Amethopterin hydrate
- AC1Q5SF6
- Methotrexate, (DL)-Isomer
- MLS002701970
- SCHEMBL3712
- C20H22N8O5
- UNII-99ITO15X8S
- D-(-)-Amethopterin hydrate
- BSPBio_000210
- BSPBio_000525
- BSPBio_001993
- Amethopterin; DL-Amethopterin
- ChEMBL_59579
- (+/-)-METHOTREXATE
- METHOTREXATE, U.S.P.
- SPECTRUM1500398
- EINECS 262-213-7
- N-Bismethylpteroylglutamic acid
- SPBio_002446
- FBOZXECLQNJBKD-UHFFFAOYSA-N
- BPBio1_000232
- BPBio1_000579
- NSC740
- orb1698477
- Methotrexate pound>>Amethopterin
- NSC 117356
- NSC-117356
- NSC-757113
- SCHEMBL11986730
- CHEBI:93775
- ERK5-1D22
- 59-05-2
- CID4112
- DTXSID40859034
- NSC 740
- TCMDC-125488
- TCMDC-125858
- C19H23N9O4
- HMS1569K07
- HMS1920L21
- HMS2091D16
- HMS2096K07
- HMS3267F07
- HMS3371G08
- HMS3403O03
- HMS3654M22
- HMS3713K07
- HMS3869E13
- HMS5079E17
- NCI-C04671
- Pharmakon1600-01500398
- BCA86579
- BCP02078
- BCP29918
- 4-Amino-10-methylfolic acid hydrate
- AR-1L5870
- BDBM50004545
- BDBM50600679
- EBC-14297
- METHOTREXATE USP AND EP GRADE
- MFCD00150847
- NSC117356
- NSC757113
- s1210
- AKOS000281496
- AKOS024282621
- C20-H22-N8-O5
- ( inverted exclamation markA)-Methotrexate
- 4-Amino-N10-methylpteroylglutamic acid
- AB02593
- CCG-212689
- EMT 25,299
- 2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid
- NCGC00015079-03
- NCGC00015079-04
- NCGC00015079-07
- NCGC00095284-01
- NCGC00095284-02
- 4CA-0097
- AC-11680
- AK-77824
- AN-39412
- CL-14377
- H023
- L-4-Amino-N10-methylpteroylglutamic acid
- LS-71811
- NCI60_041622
- SMR001565548
- ST057254
- ST069344
- 1-(4-Methoxy-2-methyl-phenyl)-piperazine
- SBI-0053664.P003
- AB0012834
- HY-121151
- Kyselina 4-amino-N10-methylpteroylglutamova
- CS-0079546
- M1664
- NS00001328
- X 133
- EN300-296152
- R 9985
- 51865-79-3
- 388A536
- SR-05000001673
- DL-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-
- I06-0203
- MTX
- SR-05000001673-1
- SR-05000001673-2
- 2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
- BRD-A55424491-001-07-4
- BRD-A55424491-001-08-2
- BRD-A55424491-001-19-9
- I14-19311
- Q27165469
- 133073-73-1
- N-(4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-DL-glutamic acid
- N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-DL-glutamic acid
- Glutamic acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, DL-
- (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid
- 2-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid
- 2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
- Amethopterin (hydrate); CL14377 (hydrate); WR19039 (hydrate)
- L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-
- (4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzoyl)glutamic acid
- N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]glutamic Acid
- (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
- (MTX)2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
- 2-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioicacid
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(MTX)
- GLUTAMIC ACID, N-(4-(((2,4-DIAMINO-6-PTERIDINYL)METHYL)METHYLAMINO)BENZOYL)-
- Glutamic acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, L-
- Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-
- Glutamic acid, N-[p-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, L-(+)-
- Kyselina N-(p-((2,4-diamino-6-pteridinylmethyl)methylamino)benzoyl)-L-glutamova
- L-(+)-N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)glutamic acid
- N-(4-(((2,4-DIAMINO-6-PTERIDINYL)METHYL)METHYLAMINO)BENZOYL)GLUTAMIC ACID
- N-(4-[[(2,4-Diamino-6-pteridinyl)methyl](methyl)amino]benzoyl)glutamic acid, (L)-
- N-(4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)glutamic acid
- N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-(+)-glutamic acid
- N-(p-((2,4-Diamino-6-pteridyl)methyl)methylamino)benzoyl)glutamic acid, (L)-
- N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-DL-glutamic acid
- (methotrexate)2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
- (Methotrexate, MTX)2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
- 1306-01-0
- 2-[(4-{[(2,4-diaminopteridin-6-yl)methyl]methylamino}phenyl)carbonylamino]pent anedioic acid
- 2-[(4-{[(4-amino-2-imino-3H-pteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid
- 2-[[[4-[(2,4-diamino-6-pteridinyl)methyl-methylamino]phenyl]-oxomethyl]amino]pentanedioic acid
- 2-[[4-[(2,4-diaminopteridin-6-yl)methyl-(trideuteriomethyl)amino]benzoyl]amino]pentanedioic acid
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid (Methotrexate)
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid (MTX)
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid bis-adamantan-1-ylamide
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(Amethopterin)
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(Methotrexate (MTX))
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(Methotrexate )
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(methotrexate(MTX))
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(Methotrexate)
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(Methotrexate, MXT)
- 262-213-7
- 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(methotrexate, MTX)
- 432545-63-6
- 87001-95-4
- Methotrexate solution, 1.0 mg/mL in methanol with 0.1N NaOH, ampule of 1 mL, certified reference material
- Methotrexate2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
- N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]glutamic Acid; (+/-)-Methotrexate; DL-Amethopterin; DL-Methotrexate; NSC 117356;